Walleye Capital’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$108K Buy
+5,499
New +$125K ﹤0.01% 5154
2025
Q4
– Sell
-8,397
Closed -$209K – 5002
2025
Q3
$209K Buy
+8,397
New +$181K ﹤0.01% 3291
2023
Q4
– Sell
-60,612
Closed -$1.39M – 5391
2023
Q3
$1.39M Buy
+60,612
New +$1.54M ﹤0.01% 2001
2023
Q1
– Sell
-19,138
Closed -$435K – 4281
2022
Q4
$435K Buy
19,138
+7,108
+59% +$198K 0.01% 1544
2022
Q3
$410K Buy
+12,030
New +$445K 0.01% 1601
2022
Q2
– Sell
-12,341
Closed -$330K – 2664
2022
Q1
$330K Sell
12,341
-19
-0.2% -$449 0.01% 1259
2021
Q4
$320K Buy
+12,360
New +$308K 0.01% 1218

Other funds holding PRVA

Walleye Capital's PRVA Position: Q3 2026 in Review

Walleye Capital opened a new position in Privia Health (PRVA) in Q3 2026: 5,499 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #5154 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PRVA as recently as Q3 2025.

Walleye Capital first reported a position in PRVA in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.39M in Q3 2023. 294 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Walleye Capital held 5,499 shares of Privia Health worth $108K as of Q3 2026.
  • Privia Health was a new Walleye Capital position in Q3 2026.
  • Privia Health made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5154 holding.
  • Walleye Capital first reported a position in Privia Health in Q4 2021 and has held it in 7 quarters since.
  • Walleye Capital's Privia Health position peaked at $1.39M in Q3 2023.
  • 294 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.